Oklo raises 2026 spending guidance to protect Aurora INL???s 2028 startup as Groves hits first criticality and fuel plans diversify.
OKLO's Q2 performance reflects rising project execution costs, emerging acquisition-driven revenues and increased spending as nuclear development accelerates.
Oklo NYSE: OKLO reported a year-to-date net loss of $81.6 million through the second quarter of 2026 while outlining progress across its power, fuel and isotope businesses, including first criticality at its Groves isotope facility in Texas and continued development of its Aurora powerhouse projects.
Oklo's Q2 surprised with $1.2M in revenue and a 14% post‑earnings jump, but the beat came from acquired businesses and doesn't yet validate the core fast‑fission model. The Groves reactor reaching first criticality in 229 days shows real execution capability, yet major uncertainties remain around Aurora‑INL's full-cost structure and expected returns. Despite stronger execution and a larger cash runway, valuation still screens neutral; the stock reflects the base‑case scenario, and more cost disclosure is needed before upgrading.
Oklo Inc. (OKLO) Q2 2026 Earnings Call Transcript
Oklo (NYSE:OKLO | OKLO Price Prediction) stock is rallying 14% today to $48.21 after the advanced nuclear developer posted its first meaningful quarterly revenue.
Oklo shares traded higher on Friday after the advanced nuclear technology company reported its first-ever quarterly revenue, significantly exceeding Wall Street expectations, even as it posted a wider-than-expected loss. The stock gained about 13.3% in trading and was on track for its biggest weekly advance in nearly four months.
Oklo (NYSE:OKLO) shares opened about 7% higher on Friday after the advanced nuclear technology company reported second quarter results that included a wider-than-expected loss but revenue that came in well above analyst estimates. The company reported a loss per share of $0.28, compared with the analyst consensus estimate of a $0.16 loss.
As OKLO gears up to report second-quarter earnings, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.
Advanced nuclear fission developer Oklo (OKLO) reached a major regulatory milestone after receiving official startup authorization from the U.S. Department of Energy (DOE) for its Groves Isotope Test Reactor in Lockhart, Texas. Key Takeaways Oklo received formal U.S.
AI-driven power demand puts Bloom Energy's commercial scale against OKLO's advanced nuclear ambitions in a high-stakes clean energy comparison.
OKLO secured DOE startup authorization for its Groves test reactor, clearing fuel loading and testing toward first criticality and isotope production.